GLANBIA PLC (GL9.I) Stock Price, Forecast & Analysis
Europe - Euronext Dublin - DUB:GL9 - IE0000669501 - Common Stock
GL9.I Key Statistics, Chart & Performance
The current stock price of GL9.I is 14.58 EUR. In the past month the price decreased by -2.55%. In the past year, price increased by 7.48%.
GL9.I Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BSN.DE | DANONE | 19.93 | 50.78B | ||
| BN.PA | DANONE | 20.07 | 51.16B | ||
| JDEP.AS | JDE PEET'S NV | 25.69 | 15.55B | ||
| JDE.DE | JDE PEET'S NV | 25.68 | 15.54B | ||
| KRZ.I | KERRY GROUP PLC-A | 15.24 | 11.88B | ||
| LOTB.BR | LOTUS BAKERIES | 43.58 | 7.03B | ||
| LOUP.PA | L.D.C. SA | 12.81 | 3.18B | ||
| SZU.DE | SUEDZUCKER AG | N/A | 1.86B | ||
| SAVE.PA | SAVENCIA SA | 9.08 | 861.44M | ||
| NWL.MI | NEWPRINCES SPA | 2.56 | 859.47M | ||
| FLOB.BR | FLORIDIENNE | 82.69 | 645.00M | ||
| BON.PA | BONDUELLE SCA | N/A | 323.69M |
Related stock screener links
About GL9.I
Company Profile
Glanbia Plc engages in the manufacture and distribution of dairy and nutritional ingredients. The company is headquartered in Kilkenny, Kilkenny and currently employs 5,791 full-time employees. The Company’s segments include Performance Nutrition, Health and Nutrition, and Dairy Nutrition. The Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products through a variety of channels including specialty, online, Food, Drug, Mass, Club (FDMC), and distributor in a variety of formats, including powders, Ready-to-Eat (bars and snacking foods) and Ready-to-Drink beverages. The Health and Nutrition segment is a global nutritional solutions business, providing value added ingredients and flavor solutions. The Dairy Nutrition segment is a producer of whey protein isolate and American-style cheddar cheese in the United States and provides a wide range of dairy and functional protein solutions. Its portfolio of brands includes Optimum Nutrition, Isopure, Nutramino, think!, and others.
Company Info
GLANBIA PLC
Glanbia House, Ring Road
KILKENNY KILKENNY IE
Employees: 5791
Phone: 353567772200
GLANBIA PLC / GL9.I FAQ
Can you describe the business of GLANBIA PLC?
Glanbia Plc engages in the manufacture and distribution of dairy and nutritional ingredients. The company is headquartered in Kilkenny, Kilkenny and currently employs 5,791 full-time employees. The Company’s segments include Performance Nutrition, Health and Nutrition, and Dairy Nutrition. The Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products through a variety of channels including specialty, online, Food, Drug, Mass, Club (FDMC), and distributor in a variety of formats, including powders, Ready-to-Eat (bars and snacking foods) and Ready-to-Drink beverages. The Health and Nutrition segment is a global nutritional solutions business, providing value added ingredients and flavor solutions. The Dairy Nutrition segment is a producer of whey protein isolate and American-style cheddar cheese in the United States and provides a wide range of dairy and functional protein solutions. Its portfolio of brands includes Optimum Nutrition, Isopure, Nutramino, think!, and others.
What is the stock price of GLANBIA PLC today?
The current stock price of GL9.I is 14.58 EUR. The price increased by 1.53% in the last trading session.
What is the dividend status of GLANBIA PLC?
GLANBIA PLC (GL9.I) has a dividend yield of 2.18%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of GL9 stock?
GL9.I has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
On which exchange is GL9.I stock listed?
GL9.I stock is listed on the Euronext Dublin exchange.
What is the expected growth for GL9 stock?
The Revenue of GLANBIA PLC (GL9.I) is expected to grow by 1.75% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the next earnings date for GL9 stock?
GLANBIA PLC (GL9.I) will report earnings on 2026-02-25.
GL9.I Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to GL9.I. When comparing the yearly performance of all stocks, GL9.I turns out to be only a medium performer in the overall market: it outperformed 46.23% of all stocks.
GL9.I Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to GL9.I. GL9.I has only an average score on both its financial health and profitability.
GL9.I Financial Highlights
Over the last trailing twelve months GL9.I reported a non-GAAP Earnings per Share(EPS) of 1.15. The EPS decreased by -58.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.06% | ||
| ROA | 3.1% | ||
| ROE | 5.89% | ||
| Debt/Equity | 0.5 |
GL9.I Forecast & Estimates
14 analysts have analysed GL9.I and the average price target is 17.91 EUR. This implies a price increase of 22.81% is expected in the next year compared to the current price of 14.58.
For the next year, analysts expect an EPS growth of -5.04% and a revenue growth 1.75% for GL9.I